InvestorsHub Logo
Followers 0
Posts 40
Boards Moderated 0
Alias Born 06/04/2015

Re: None

Friday, 02/16/2018 9:10:26 AM

Friday, February 16, 2018 9:10:26 AM

Post# of 3683
This is the one I'm referring to:
Athersys Poised For Lucrative Stem Cell Stroke Partnership This Year
May 16, 2017 6:23 AM ET|112 comments| About: Athersys, Inc. (ATHX), Includes: RTIX
This article is now exclusive for PRO subscribers.
Wall Street Titan
Wall Street Titan
Regenerative Medicine, small-cap, alternative energy
MARKETPLACEStem Cell News and Analysis

Get email alerts
Summary
Fast Track and Special Protocol Assessment designations sets stage for global stroke partnership in 2017.

$1,000,000 milestone payment indicates that Athersys's proprietary MAPCs are performing in real-world clinical application.

Mystery surrounding Japan stroke patient enrollment delay resolved.

Over the last few months, several SA followers have requested an update on stem cell biotech, Athersys Inc. (NASDAQ:ATHX). Realistically, there really hadn't been any significant developments worthy of an update over the......